Targacept Inc. Hits New 52-Week High at $5.78 (TRGT)
Shares of Targacept (NASDAQ:TRGT) hit a new 52-week high on Wednesday, AR Network reports. The company traded as high as $5.78 and last traded at $5.68, with a volume of 86,001 shares trading hands. The stock had previously closed at $5.72.
Several analysts have recently commented on the stock. Analysts at Zacks downgraded shares of Targacept (NASDAQ:TRGT) from an “outperform” rating to a “neutral” rating in a research note to investors on Thursday, July 25th. They now have a $5.70 price target on the stock.
Targacept has a 52-week low of $3.85 and a 52-week high of $5.77. The stock’s 50-day moving average is $5. and its 200-day moving average is $4.81. The company’s market cap is $191.1 million.
Targacept (NASDAQ:TRGT) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.37) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.37). During the same quarter last year, the company posted $0.43 earnings per share. Analysts expect that Targacept will post $-1.36 EPS for the current fiscal year.
Targacept, Inc is a biopharmaceutical company. The Company is engaged in the design, discovery and development of NNR Therapeutics for the treatment of diseases and disorders of the nervous system.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.